This inventor holds 1 USPTO granted patent. Top assignee: Walter and Eliza Hall Institute of Medical Research. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Edward James McManus: Innovator in SOCS3 Protein Research
Introduction
Edward James McManus is a notable inventor based in Clifton Hill, Australia. He has made significant contributions to the field of medical research, particularly in the study of Suppressor of Cytokine Signalling (SOCS) proteins. His work focuses on enhancing the stability and functionality of these proteins, which are crucial in various biological processes.
Latest Patents
McManus holds a patent related to SOCS3 proteins. The invention pertains to the identification of a PEST motif in SOCS proteins. The deletion or inactivation of this motif has been found to increase the stability of the protein while maintaining at least one biological activity. This advancement allows for the development of SOCS proteins that are more stable than their native counterparts, making them valuable for gene and protein therapy procedures. Additionally, the patent includes methods for characterizing the structure of SOCS proteins and identifying compounds that can modulate their activity.
Career Highlights
Edward James McManus is affiliated with the Walter and Eliza Hall Institute of Medical Research. His research has contributed to a deeper understanding of SOCS proteins and their potential applications in therapeutic settings. His innovative approach has positioned him as a key figure in the field of medical research.
Collaborations
McManus has collaborated with esteemed colleagues such as Raymond Stanley Norton and Jeffrey James Babon. These partnerships have furthered the exploration of SOCS proteins and their implications in medical science.
Conclusion
Edward James McManus is a pioneering inventor whose work on SOCS3 proteins has the potential to revolutionize gene and protein therapy. His contributions to the field highlight the importance of innovation in medical research.